Acute oscillations in blood glucose are associated with negative outcomes in diabetes. Many believe such oscillations may be a significant risk factor for diabetes complications beyond the average glycemic exposure.
There can be a number of factors that come into play when a thin person develops type 2 diabetes. Genetics play a significant role in determining disease onset. A strong family history coupled with a sedentary lifestyle and poor eating habits can tip the scales in the wrong direction.
If you are one of the majority of people with diabetes without a formal care plan in place, consider talking with your doctor about creating one right away. In an ideal world, every physician would ask T1 patients about a plan, but in reality it’s going to be up to patients to take the initiative.
The HDV compound would be injected or swallowed as a pill where it would attach to insulin, causing the insulin to be better absorbed into the liver’s metabolic cells before being released back into the bloodstream. In short, this could be an insulin delivery game-changer.
If you have a high blood sugar during meal time and you use matching insulin to carbohydrate as your method of dosing insulin, you should be able to use your correction factor to cover the high blood sugar and then give the appropriate dose of insulin for the meal.
Afternoon moderate-to-vigorous physical activity (MVPA) increases the risk of overnight and next-day hypoglycemia in adolescents with type 1 diabetes, according to research published in the May issue of Diabetes Care.
While the majority of new diabetes diagnoses in children are still type 1 – about 13,000 a year – the escalating numbers of type 2 cases, previously only seen in middle-aged people, is alarming.
April showers bring May flowers… or so they say. In 2014, many parts of the country are just now starting to warm up a bit after a crazy-cold winter, with ice and snow blasting the Midwest even into this month! Here’s our very own monthly diabetes “blog carnival,” in no particular order.
Cynthia Sass is a registered dietitian with master’s degrees in both nutrition science and public health, and the author of “S.A.S.S! Yourself Slim: Conquer Cravings, Drop Pounds and Lose Inches.”
Eighth grader Amelia Cooper and her father Blake recently stopped by the diaTribe office in San Francisco for her middle school career day. After publishing our learning curve last month on tips for patients newly diagnosed people with type 1 diabetes, we wondered what Amelia wished she had said to her parents, friends, and the […]
There’s a lot of novel work happening in the diabetes research world on new types of glucagon, from Epi-Pen delivery devices to work on stable forms that could be used in infusion pumps along with insulin
Previous research has shown that extreme increases in glucose and insulin in the blood can lead to poor glucose control and increase an individual’s risk of developing diabetes over time. Now, a researcher has found that when women consumed high-protein breakfasts, they maintained better glucose and insulin control than they did with lower-protein or no-protein […]
In a potential step toward new diabetes treatments, scientists used a cloning technique to make insulin-producing cells with the DNA of a diabetic woman. The approach could someday aid treatment of the Type 1 form of the illness, which is usually diagnosed in childhood and accounts for about 5 percent of diabetes cases in the […]
Have you ever asked yourself, “How did I get type 1 diabetes?”. 23andMe is a privately held personal genomics and biotechnology company based in Mountain View, California that provides rapid genetic testing. This compay may be able to offer a non-conclusive answer to this question.
Insulin prescription errors rank first among all prescribed drugs. In an effort to remedy this problem, Eli Lilly is developing a prefilled pen for delivering Humulin R U-500 insulin as well as collaborating on the development of a dedicated U-500 syringe.
Researchers examined trends in the incidence of diabetes-related complications, between 1900 and 2010. Over the past two decades, the rates of myocardial infarctions and strokes in diabetic patients has dropped by over 60% according to a recent study.
The system makes a huge stride in making it easier to quickly download glucose data, analyze it, and make some diabetes management changes using your smartphone. The Verio Sync’s accompanying app – OneTouch Reveal – is the major highlight of the system.
Cleveland-based Thermalin said today that JDRF will provide it with up to $1 million for specific milestones related to identifying a clinical candidate insulin analog with a shorter tail of action.
For those of you out of the loop, “brittle” is an old-fashioned word for diabetes that’s almost impossible to control despite the best efforts. Nowadays, medical pros prefer to blame the patient when things go wrong, rather than accept the possibility there might be a flavor of diabetes that can’t be controlled
Oramed Pharmaceuticals Inc. announced detailed results from its previously completed Phase 2a trial investigating ORMD-0801, its orally ingestible insulin capsule, in type 2 diabetes patients. The preliminary results of this trial were originally announced on Jan. 30, 2014